Literature DB >> 20638297

Insulin signaling meets mitochondria in metabolism.

Zhiyong Cheng1, Yolanda Tseng, Morris F White.   

Abstract

Insulin controls nutrient and metabolic homeostasis via the IRS-PI3K-AKT signaling cascade that targets FOXO1 and mTOR. Mitochondria, as the prime metabolic platform, malfunction during insulin resistance in metabolic diseases. However, the molecular link between insulin resistance and mitochondrial dysfunction remains undefined. Here we review recent studies on insulin action and the mechanistic association with mitochondrial metabolism. These studies suggest that insulin signaling underpins mitochondrial electron transport chain integrity and activity by suppressing FOXO1/HMOX1 and maintaining the NAD(+)/NADH ratio, the mediator of the SIRT1/PGC1α pathway for mitochondrial biogenesis and function. Mitochondria generate moderately reactive oxygen species (ROS) and enhance insulin sensitivity upon redox regulation of protein tyrosine phosphatase and insulin receptor. However, chronic exposure to high ROS levels could alter mitochondrial function and thereby cause insulin resistance.
Copyright © 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20638297      PMCID: PMC3994704          DOI: 10.1016/j.tem.2010.06.005

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  117 in total

1.  Foxo1 in hepatic lipid metabolism.

Authors:  Zhiyong Cheng; Morris F White
Journal:  Cell Cycle       Date:  2010-01-06       Impact factor: 4.534

2.  Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.

Authors:  Ryaz B Chagpar; Philip H Links; M Chris Pastor; Levi A Furber; Andrea D Hawrysh; M Dean Chamberlain; Deborah H Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

3.  Roles of superoxide radical anion in signal transduction mediated by reversible regulation of protein-tyrosine phosphatase 1B.

Authors:  W C Barrett; J P DeGnore; Y F Keng; Z Y Zhang; M B Yim; P B Chock
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

Review 4.  Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models.

Authors:  Zhiyong Cheng; Morris F White
Journal:  Antioxid Redox Signal       Date:  2010-09-16       Impact factor: 8.401

5.  Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein.

Authors:  B J Goldstein; A Bittner-Kowalczyk; M F White; M Harbeck
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

6.  Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis.

Authors:  Shijie Li; Michael S Brown; Joseph L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

7.  Foxo1 integrates insulin signaling with mitochondrial function in the liver.

Authors:  Zhiyong Cheng; Shaodong Guo; Kyle Copps; Xiaochen Dong; Ramya Kollipara; Joseph T Rodgers; Ronald A Depinho; Pere Puigserver; Morris F White
Journal:  Nat Med       Date:  2009-10-18       Impact factor: 53.440

8.  Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans.

Authors:  Ethan J Anderson; Mary E Lustig; Kristen E Boyle; Tracey L Woodlief; Daniel A Kane; Chien-Te Lin; Jesse W Price; Li Kang; Peter S Rabinovitch; Hazel H Szeto; Joseph A Houmard; Ronald N Cortright; David H Wasserman; P Darrell Neufer
Journal:  J Clin Invest       Date:  2009-02-02       Impact factor: 14.808

Review 9.  An emerging role of mTOR in lipid biosynthesis.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Curr Biol       Date:  2009-12-01       Impact factor: 10.834

10.  Insulin signaling regulates mitochondrial function in pancreatic beta-cells.

Authors:  Siming Liu; Terumasa Okada; Anke Assmann; Jamie Soto; Chong Wee Liew; Heiko Bugger; Orian S Shirihai; E Dale Abel; Rohit N Kulkarni
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more
  150 in total

Review 1.  Redox regulation of mitochondrial function.

Authors:  Diane E Handy; Joseph Loscalzo
Journal:  Antioxid Redox Signal       Date:  2012-02-03       Impact factor: 8.401

2.  BNip3 regulates mitochondrial function and lipid metabolism in the liver.

Authors:  Danielle Glick; Wenshuo Zhang; Michelle Beaton; Glenn Marsboom; Michaela Gruber; M Celeste Simon; John Hart; Gerald W Dorn; Matthew J Brady; Kay F Macleod
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

Review 3.  Mitochondrial function in ageing: coordination with signalling and transcriptional pathways.

Authors:  Fei Yin; Harsh Sancheti; Zhigang Liu; Enrique Cadenas
Journal:  J Physiol       Date:  2015-09-16       Impact factor: 5.182

4.  MicroRNA-432 targeting E2F3 and P55PIK inhibits myogenesis through PI3K/AKT/mTOR signaling pathway.

Authors:  Meilin Ma; Xiangming Wang; Xiaochang Chen; Rui Cai; Fenfen Chen; Wuzi Dong; Gongshe Yang; Weijun Pang
Journal:  RNA Biol       Date:  2017-01-13       Impact factor: 4.652

5.  The proteomic signature of insulin-resistant human skeletal muscle reveals increased glycolytic and decreased mitochondrial enzymes.

Authors:  J Giebelstein; G Poschmann; K Højlund; W Schechinger; J W Dietrich; K Levin; H Beck-Nielsen; K Podwojski; K Stühler; H E Meyer; H H Klein
Journal:  Diabetologia       Date:  2012-01-27       Impact factor: 10.122

6.  Glycogen phosphorylase inhibition improves beta cell function.

Authors:  Lilla Nagy; Judit Márton; András Vida; Gréta Kis; Éva Bokor; Sándor Kun; Mónika Gönczi; Tibor Docsa; Attila Tóth; Miklós Antal; Pál Gergely; Balázs Csóka; Pal Pacher; László Somsák; Péter Bai
Journal:  Br J Pharmacol       Date:  2017-06-18       Impact factor: 8.739

7.  Proline oxidase-adipose triglyceride lipase pathway restrains adipose cell death and tissue inflammation.

Authors:  D Lettieri Barbato; K Aquilano; S Baldelli; S M Cannata; S Bernardini; G Rotilio; M R Ciriolo
Journal:  Cell Death Differ       Date:  2013-10-04       Impact factor: 15.828

Review 8.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

Review 9.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

10.  Insulin receptor substrate-2 is expressed in kidney epithelium and up-regulated in diabetic nephropathy.

Authors:  Michelle B Hookham; Helen C O'Donovan; Rachel H Church; Annie Mercier-Zuber; Lucilla Luzi; Simon P Curran; Rosemarie M Carew; Alejandra Droguett; Sergio Mezzano; Markus Schubert; Morris F White; John K Crean; Derek P Brazil
Journal:  FEBS J       Date:  2013-05-29       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.